Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index.
Ta-Wei LiuChung-Feng HuangMing-Lun YehPei-Chien TsaiTyng-Yuan JangJee-Fu HuangChia-Yen DaiWan-Long ChuangMing-Lung YuPublished in: BMJ open gastroenterology (2021)
Chronic hepatitis B patients not meeting the reimbursement criteria of the Taiwan NHI are prone to increment of liver fibrosis marker. Overweight is associated with less increment of fibrosis marker, while initial FIB-4 <1.29 is associated with increasing fibrosis marker.